Literature DB >> 17277748

CRMP-5-IgG in patient with paraneoplastic optic neuritis with lung adenocarcinoma.

Y Murakami, S Yoshida, H Yoshikawa, Y Yamaji, Y Ikeda, A Ueno, T Ishibashi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17277748     DOI： 10.1038/sj.eye.6702730

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

1.  Paraneoplastic optic neuropathy associated with cerebellar choroid meningioma.

Authors:  S Nakano; A Kanamori; M Nakamura; K Mizukawa; A Negi
Journal:  Eye (Lond)       Date:  2013-07-12       Impact factor: 3.775

Review 2.  Atypical Optic Neuritis.

Authors:  Eric D Gaier; Katherine Boudreault; Joseph F Rizzo; Julie Falardeau; Dean M Cestari
Journal:  Curr Neurol Neurosci Rep       Date:  2015-12       Impact factor: 5.081

3.  Paraneoplastic optic neuritis as the first manifestation of periampullary carcinoma.

Authors:  Rudrajit Paul; Asim K Ghosh; Avirup Sinha; Raja Bhattacharya
Journal:  Int J Appl Basic Med Res       Date:  2015 Jan-Apr

4.  CV2/CRMP5-antibody-related Paraneoplastic Optic Neuropathy Associated with Small-cell Lung Cancer.

Authors:  Masanori Nakajima; Ayumi Uchibori; Yuki Ogawa; Tai Miyazaki; Yaeko Ichikawa; Kimihiko Kaneko; Toshiyuki Takahashi; Ichiro Nakashima; Hirokazu Shiraishi; Masakatsu Motomura; Atsuro Chiba
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271

5.  CRMP-5-IgG Antibody: role in the bilateral uveitis with swollen disc.

Authors:  Laura Hernández-Bel; Francisco Puchades-Gimeno; Amaya Fernandez-Diaz; Lucía Mata-Moret; Emma Beltrán-Catalán; María Luísa Hernandez-Garfella; Enrique Cervera-Taulet
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

6.  Vision Improvement after Osimertinib Treatment in Paraneoplastic Optic Neuropathy Associated with Lung Adenocarcinoma.

Authors:  Masaomi Kubota; Nobumasa Tamura; Takaaki Hayashi; Euido Nishijima; Haruhiko Yanagisawa; Akira Kojima; Tadashi Nakano
Journal:  Case Rep Ophthalmol Med       Date:  2021-07-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.